Brilinta (Ticagrelor)

Save over 75% with European Brilinta and generic Brilinta.

Click here for information on Sun Pharma generics (Immediate availability)

Brilinta is called Brilique in Europe.

Information about Brilinta (Ticagrelor)

Brilinta is a prescription medication used to reduce the risk of heart attack, stroke, and other cardiovascular events in individuals with acute coronary syndrome (ACS) or a history of heart problems. It works as an antiplatelet agent, helping to prevent blood clots from forming.

Ticagrelor is the active ingredient in Brilinta. It is a P2Y12 receptor inhibitor that prevents platelets in the blood from sticking together and forming clots.

Product Highlights:

• Used to reduce the risk of cardiovascular events, including heart attack, stroke, and death in patients with acute coronary syndrome (ACS) or a history of heart disease.
• Ticagrelor is a P2Y12 platelet receptor antagonist that prevents platelets from aggregating (clumping together), thus reducing the likelihood of clot formation.
• Offers a quick onset of action compared to some other antiplatelet drugs, making it effective in acute situations.

Key Ingredient:

• Ticagrelor

Key Benefits:

• Significantly lowers the chance of heart attack, stroke, and death from heart disease in people with ACS.
• Provides rapid antiplatelet effects compared to some other medications in its class.
• Helps in reducing the risk of stent thrombosis in patients undergoing coronary stent placement.

Direction of Use:

• Typically, the initial dose is 180 mg, followed by a maintenance dose of 90 mg twice daily. This dosage may be adjusted based on individual patient needs and medical conditions.
• Take the tablet orally with or without food. It's essential to follow the prescribed dosage and schedule exactly as directed by a healthcare provider.

Safety Concerns:

• Brilinta increases the risk of bleeding, including serious bleeding events. Patients should be monitored for signs of bleeding and advised to report any unusual bleeding or bruising immediately.
• May interact with other medications, including blood thinners, certain antidepressants, and drugs that affect liver enzymes.
• Common side effects include shortness of breath, bleeding, headache, and dizziness. More severe side effects could include severe bleeding or allergic reactions.

Avoid Brilinta (Ticagrelor) If:

• If you have a condition that causes active bleeding, such as a stomach ulcer or bleeding disorder.
• In cases of severe liver disease or dysfunction.
• If you have a known hypersensitivity or allergic reaction to ticagrelor or any other component of the medication.
• It’s generally recommended to avoid Brilinta during pregnancy and breastfeeding unless clearly needed and prescribed by a healthcare provider.